According to Nxera Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.18. At the end of 2024 the company had a P/S ratio of 5.75.
Year | P/S ratio | Change |
---|---|---|
2024 | 5.75 | -38.03% |
2023 | 9.29 | -20.4% |
2022 | 11.7 | 34.22% |
2021 | 8.69 | -47.95% |
2020 | 16.7 | -3.21% |
2019 | 17.3 | 0.31% |
2018 | 17.2 | -26.26% |
2017 | 23.3 | 102.38% |
2016 | 11.5 | -27.91% |
2015 | 16.0 | -66.11% |
2014 | 47.2 | 88.3% |
2013 | 25.1 | 103.13% |
2012 | 12.3 | -32.48% |
2011 | 18.3 | -18.85% |
2010 | 22.5 | 57.94% |
2009 | 14.3 |